BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.06B |
| 2 |
Tesla
TSLA
|
+$468M |
| 3 |
AbbVie
ABBV
|
+$312M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$266M |
| 5 |
Abbott
ABT
|
+$254M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Invesco QQQ Trust
QQQ
|
+$609M |
| 2 |
Apple
AAPL
|
+$577M |
| 3 |
Visa
V
|
+$476M |
| 4 |
iShares MSCI ACWI ETF
ACWI
|
+$434M |
| 5 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$239M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.37% |
| 2 | Financials | 8.23% |
| 3 | Consumer Discretionary | 6.83% |
| 4 | Healthcare | 6.12% |
| 5 | Communication Services | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
3526
Wrap Technologies
WRAP
$96.4M
| $12.8K | ﹤0.01% |
1,629
-72
| -4% | -$493 |
|
3527
Transcat
TRNS
$915M
| $12.7K | ﹤0.01% |
225
-590
| -72% | -$30.7K |
|
|
HARP
3528
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $12.7K | ﹤0.01% |
92
-78
| -46% | -$14.9K |
|
3529
Lexicon Pharmaceuticals
LXRX
$1.05B
| $12.7K | ﹤0.01% |
2,757
-4,041
| -59% | -$19.5K |
|
3530
Full House Resorts
FLL
$83.5M
| $12.5K | ﹤0.01% |
+1,260
| New | +$12.2K |
|
3531
Franklin Financial Services
FRAF
$289M
| $12.5K | ﹤0.01% |
390
-1,567
| -80% | -$47.6K |
|
|
TBHC
3532
DELISTED
The Brand House Collective
TBHC
| $12.4K | ﹤0.01% |
+540
| New | +$14.5K |
|
3533
Cue Biopharma
CUE
$128M
| $12.3K | ﹤0.01% |
35
-89
| -72% | -$34.5K |
|
|
EPIX
3534
DELISTED
ESSA Pharma
EPIX
| $12.3K | ﹤0.01% |
+431
| New | +$12.5K |
|
3535
iRadimed
IRMD
$1.12B
| $12.3K | ﹤0.01% |
418
-320
| -43% | -$8.82K |
|
3536
Savara
SVRA
$1.17B
| $12.3K | ﹤0.01% |
7,225
-12,411
| -63% | -$22.3K |
|
3537
Rekor Systems
REKR
$94M
| $12.3K | ﹤0.01% |
+1,208
| New | +$18.5K |
|
|
AMPE
3538
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
| $12.2K | ﹤0.01% |
+24
| New | +$12.9K |
|
3539
First Business Financial Services
FBIZ
$593M
| $12.2K | ﹤0.01% |
450
-3,696
| -89% | -$97.5K |
|
3540
KALA BIO
KALA
$17.1M
| $12.1K | ﹤0.01% |
1
-1
| -50% | -$15.7K |
|
|
CVLY
3541
DELISTED
Codorus Valley Bancorp Inc
CVLY
| $12.1K | ﹤0.01% |
603
-3,704
| -86% | -$69.6K |
|
3542
Wave Life Sciences
WVE
$1.03B
| $12K | ﹤0.01% |
1,805
-2,389
| -57% | -$15.6K |
|
3543
Puma Biotechnology
PBYI
$459M
| $12K | ﹤0.01% |
1,309
-6,308
| -83% | -$63.9K |
|
3544
BayCom
BCML
$341M
| $12K | ﹤0.01% |
669
-3,419
| -84% | -$62.1K |
|
|
EXPR
3545
DELISTED
Express, Inc.
EXPR
| $11.9K | ﹤0.01% |
92
-1,381
| -94% | -$117K |
|
3546
CB Financial Services
CBFV
$192M
| $11.9K | ﹤0.01% |
537
-2,107
| -80% | -$45.9K |
|
3547
UroGen Pharma
URGN
$2.39B
| $11.8K | ﹤0.01% |
774
-3,665
| -83% | -$66.3K |
|
3548
SIGA Technologies
SIGA
$206M
| $11.8K | ﹤0.01% |
1,872
-5,606
| -75% | -$38.5K |
|
3549
Riverview Bancorp
RVSB
$106M
| $11.7K | ﹤0.01% |
1,657
-9,198
| -85% | -$63.6K |
|
|
SYRS
3550
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
| $11.7K | ﹤0.01% |
215
-401
| -65% | -$23.7K |
|
Similar funds
BNP Paribas Financial Markets's Q2 2021 Portfolio in Review
As of Q2 2021, BNP Paribas Financial Markets held 4,172 positions worth $75.6B, up 11% from $68.3B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
BNP Paribas Financial Markets's Q2 2021 filing shows 175 new, 1,539 increased, 1,937 reduced and 124 closed positions. Its largest new stake was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M. The largest sale was Invesco QQQ Trust, an estimated $609M.
By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 13% a quarter earlier, followed by Financials and Consumer Discretionary.
- BNP Paribas Financial Markets's largest Q2 2021 buy was FlexShares Global Upstream Natural Resources Index Fund: 708,078 shares worth $27.1M.
- BNP Paribas Financial Markets added most to State Street SPDR S&P 500 ETF Trust in Q2 2021, an estimated $1.06B increase.
- BNP Paribas Financial Markets's biggest Q2 2021 reduction was Invesco QQQ Trust, cutting an estimated $609M.
- BNP Paribas Financial Markets fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $123M.
- BNP Paribas Financial Markets's ten largest holdings make up 13% of its $75.6B portfolio in Q2 2021.
- BNP Paribas Financial Markets opened 175 new positions and closed 124 in Q2 2021.
- BNP Paribas Financial Markets's portfolio value rose 11% quarter-over-quarter to $75.6B.
Based on BNP Paribas Financial Markets's 13F filing for Q2 2021, filed 10 Aug 2021.